| Dr Deepthi Gandhiraj, MD | |
|
981 State Highway 121 Ste 1100, Allen, TX 75013-6148 | |
| (737) 758-4049 | |
| (888) 905-2543 |
| Full Name | Dr Deepthi Gandhiraj |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine - Pulmonary Disease |
| Location | 981 State Highway 121 Ste 1100, Allen, Texas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144621012 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0200X | Internal Medicine - Critical Care Medicine | T4365 (Texas) | Secondary |
| 207RP1001X | Internal Medicine - Pulmonary Disease | T4365 (Texas) | Primary |
| Entity Name | Hospital Authority Of Valdosta And Lowndes County Georgia |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1518382217 PECOS PAC ID: 1355334509 Enrollment ID: O20140505001975 |
News Archive
The invention of the EPICUP epigenetic test last year allowed physicians to elucidate what type of primary tumor had metastasized in patients with Cancer of Unknown Primary (CUP).
A shorter, five-week course of radiation treatment that delivers higher doses of radiation in fewer sessions, known as hypofractionation, appears to be just as effective and as safe in reducing the risk of prostate cancer from returning as standard radiation therapy, yet is delivered in two-and-a-half weeks less time, according to interim results of a randomized study presented November 4, 2009, at the 51st Annual Meeting of the American Society for Radiation Oncology (ASTRO).
The University of Illinois today announces that Chromatin, Inc., a biotechnology company that has occupied space in the University's Research Park since 2005 as part of the EnterpriseWorks incubator, is expanding operations and graduating to a 5,000 square foot facility in the Research Park. The expansion marks the company's continued significant progress in commercializing its proprietary technology, including mini-chromosomes which were originally developed at the University of Chicago by company co-founder and CEO Daphne Preuss.
Asian Healthcare industry sets to network with almost 2000 international delegates from around the globe to understand latest trends of rapidly growing medical tourism industry as they participate at large in world's largest medical tourism and global health congress in Los Angeles on Oct 26th-28th.
› Verified 3 days ago
| Entity Name | Sgmc Physician Network Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417597170 PECOS PAC ID: 4082036843 Enrollment ID: O20201015000629 |
News Archive
The invention of the EPICUP epigenetic test last year allowed physicians to elucidate what type of primary tumor had metastasized in patients with Cancer of Unknown Primary (CUP).
A shorter, five-week course of radiation treatment that delivers higher doses of radiation in fewer sessions, known as hypofractionation, appears to be just as effective and as safe in reducing the risk of prostate cancer from returning as standard radiation therapy, yet is delivered in two-and-a-half weeks less time, according to interim results of a randomized study presented November 4, 2009, at the 51st Annual Meeting of the American Society for Radiation Oncology (ASTRO).
The University of Illinois today announces that Chromatin, Inc., a biotechnology company that has occupied space in the University's Research Park since 2005 as part of the EnterpriseWorks incubator, is expanding operations and graduating to a 5,000 square foot facility in the Research Park. The expansion marks the company's continued significant progress in commercializing its proprietary technology, including mini-chromosomes which were originally developed at the University of Chicago by company co-founder and CEO Daphne Preuss.
Asian Healthcare industry sets to network with almost 2000 international delegates from around the globe to understand latest trends of rapidly growing medical tourism industry as they participate at large in world's largest medical tourism and global health congress in Los Angeles on Oct 26th-28th.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Deepthi Gandhiraj, MD 981 State Highway 121 Ste 1100, Allen, TX 75013-6148 Ph: (281) 468-9920 | Dr Deepthi Gandhiraj, MD 981 State Highway 121 Ste 1100, Allen, TX 75013-6148 Ph: (737) 758-4049 |
News Archive
The invention of the EPICUP epigenetic test last year allowed physicians to elucidate what type of primary tumor had metastasized in patients with Cancer of Unknown Primary (CUP).
A shorter, five-week course of radiation treatment that delivers higher doses of radiation in fewer sessions, known as hypofractionation, appears to be just as effective and as safe in reducing the risk of prostate cancer from returning as standard radiation therapy, yet is delivered in two-and-a-half weeks less time, according to interim results of a randomized study presented November 4, 2009, at the 51st Annual Meeting of the American Society for Radiation Oncology (ASTRO).
The University of Illinois today announces that Chromatin, Inc., a biotechnology company that has occupied space in the University's Research Park since 2005 as part of the EnterpriseWorks incubator, is expanding operations and graduating to a 5,000 square foot facility in the Research Park. The expansion marks the company's continued significant progress in commercializing its proprietary technology, including mini-chromosomes which were originally developed at the University of Chicago by company co-founder and CEO Daphne Preuss.
Asian Healthcare industry sets to network with almost 2000 international delegates from around the globe to understand latest trends of rapidly growing medical tourism industry as they participate at large in world's largest medical tourism and global health congress in Los Angeles on Oct 26th-28th.
› Verified 3 days ago
Dr. Yamini K Maddala, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 981 State Highway 121, Suite 1140, Allen, TX 75013 Phone: 469-697-5100 Fax: 469-697-5105 | |
Kathryn Anne White, D.O. Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 1105 Central Expy N Ste 235, Allen, TX 75013 Phone: 972-747-6042 | |
Dr. Olubukola Aduke Okoro, M.D Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 997 Raintree Cir Ste 130, Allen, TX 75013 Phone: 763-443-3926 Fax: 972-390-1050 | |
Deepti Dhavaleshwar, Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 981 State Highway 121, Suite 1140, Allen, TX 75013 Phone: 469-697-5100 Fax: 469-697-5105 | |
Asif A Muhammad, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 935 W Exchange Pkwy, Suite 100, Allen, TX 75013 Phone: 214-383-0938 Fax: 214-383-9851 | |
Dr. Teresa Dewlett Rajala, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 1314 W Mcdermott Dr, Suite 106, Pmb 808, Allen, TX 75013 Phone: 469-252-0022 Fax: 214-383-9587 | |
Dr. Ferzana Mir, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1105 Central Expy N, Suite 2360, Allen, TX 75013 Phone: 972-838-1892 |